ZBIO

Zenas BioPharma, Inc. Common Stock
ZBIO

Overview Fund Activity

65 hedge funds and large institutions have $260M invested in Zenas BioPharma, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
+22
Holders Change %
+51.16%
% of All Funds
0.87%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
36
Increased
13
Reduced
6
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
BlackRock
New York
$8.24M
2
Vanguard Group
Vanguard Group
Pennsylvania
$8.02M
3
NHAS
Novo Holdings A/S
Denmark
$13.1M
4
ACH
ArrowMark Colorado Holdings
Colorado
$5.14M
5
Geode Capital Management
Geode Capital Management
Massachusetts
$2.86M

Top Sellers

1
PA
Perceptive Advisors
New York
$6.09M
2
Wellington Management Group
Wellington Management Group
Massachusetts
$9.17M
3
MIM
Monashee Investment Management
Massachusetts
$0
4
Fidelity Investments
Fidelity Investments
Massachusetts
$14.6M
5
Aberdeen Group
Aberdeen Group
United Kingdom
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SOCM
1
SR One Capital Management
Pennsylvania
$40.2M – – –
ES
2
Enavate Sciences
California
$30.8M +$30.8M +3,761,359 New
NMC
3
NEA Management Company
Maryland
$21.4M – – –
FFM
4
Fairmount Funds Management
Pennsylvania
$15.5M – – –
NA
5
NVP Associates
California
$15.1M – – –
Fidelity Investments
6
Fidelity Investments
Massachusetts
$14.6M -$1.79M -218,285 -11%
NHAS
7
Novo Holdings A/S
Denmark
$13.1M +$3.69M +450,000 +39%
DM
8
Deerfield Management
New York
$12.8M – – –
VC
9
Vivo Capital
California
$9.69M – – –
Federated Hermes
10
Federated Hermes
Pennsylvania
$9.48M – – –
Wellington Management Group
11
Wellington Management Group
Massachusetts
$9.17M -$2.96M -366,139 -24%
BlackRock
12
BlackRock
New York
$8.24M +$8.24M +1,006,558 New
Vanguard Group
13
Vanguard Group
Pennsylvania
$8.02M +$6.79M +829,323 +553%
RSCM
14
Rock Springs Capital Management
Maryland
$7.2M – – –
PA
15
Perceptive Advisors
New York
$6.09M -$3.28M -400,000 -35%
PBPIA
16
Pivotal bioVenture Partners Investment Advisor
California
$6.03M +$704K +85,950 +13%
ACH
17
ArrowMark Colorado Holdings
Colorado
$5.14M +$2.68M +327,669 +109%
T. Rowe Price Associates
18
T. Rowe Price Associates
Maryland
$4.19M +$200K +24,366 +5%
Morgan Stanley
19
Morgan Stanley
New York
$2.93M +$2.52M +307,162 +602%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$2.86M +$2.65M +323,903 +1,303%
State Street
21
State Street
Massachusetts
$1.73M +$1.73M +211,506 New
Schroder Investment Management Group
22
Schroder Investment Management Group
United Kingdom
$1.55M +$1.55M +171,940 New
CCM
23
Catalio Capital Management
New York
$1.53M +$1.53M +187,184 New
EP
24
Eversept Partners
New York
$1.41M -$151K -18,428 -10%
Millennium Management
25
Millennium Management
New York
$1.1M +$143K +17,515 +15%
1
2 3 4